Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD - Wikidata - awgldk - TriplyDB

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

http://www.wikidata.org/entity/Q28258977

about

Combination of thiopurines and allopurinol: adverse events and clinical benefit in IBD Use of thiopurines in inflammatory bowel disease Thiopurine monitoring in children with inflammatory bowel disease: a systematic review How I treat my inflammatory bowel disease-patients with thiopurines?Optimizing the use of thiopurines in inflammatory bowel disease NUDT15 polymorphisms alter thiopurine metabolism and hematopoietic toxicity Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?Nodular regenerative liver hyperplasia as a complication of azathioprine-containing immunosuppressive treatment for Crohn's disease.Review article: the association between nodular regenerative hyperplasia, inflammatory bowel disease and thiopurine therapy.Incidence, timing, and risk factors of azathioprine hepatotoxicosis in dogs.6-methylmercaptopurine-induced leukocytopenia during thiopurine therapy in inflammatory bowel disease patients.Thiopurine use associated with reduced B and natural killer cells in inflammatory bowel disease Safety and efficacy of the immunosuppressive agent 6-tioguanine in murine model of acute and chronic colitis.Influence of 5-aminosalicylic acid on 6-thioguanosine phosphate metabolite levels: a prospective study in patients under steady thiopurine therapy.Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine Targeting GTPases in Parkinson's disease: comparison to the historic path of kinase drug discovery and perspectives Thiopurines in inflammatory bowel disease revisited Thiopurine Prodrugs Mediate Immunosuppressive Effects by Interfering with Rac1 Protein Function.The first cases of collagenous sprue successfully treated with thioguanine.Therapeutic strategies for the management of ulcerative colitis.Efficacy of thioguanine treatment in inflammatory bowel disease: A systematic review.Hepatic inflammation and progressive liver fibrosis in chronic liver disease.Hepatobiliary associations with inflammatory bowel disease.Review article: the role of non-biological drugs in refractory inflammatory bowel disease.Recent advances using immunomodulators for inflammatory bowel disease.The role and advances of immunomodulator therapy for inflammatory bowel disease.Eosinophilic granulomatosis with polyangiitis: an overview.A practical guide to the use of thiopurines in oral medicine.Toxicity and response to thiopurines in patients with inflammatory bowel disease.Thiopurine metabolite testing in inflammatory bowel disease.6-mercaptopurine promotes energetic failure in proliferating T cells.Tofacitinib for the treatment of ulcerative colitis.Pharmacology of Thiopurine Therapy in Inflammatory Bowel Disease and Complete Blood Cell Count Outcomes: A 5-Year Database Study Nodular regenerative hyperplasia rarely leads to liver transplantation: A 20-year cohort study in all Dutch liver transplant units.Thiopurine therapy in inflammatory bowel disease patients: analyses of two 8-year intercept cohorts.Allopurinol safely and effectively optimises thiopurine metabolites in patients with autoimmune hepatitis.Thiopurines during pregnancy in inflammatory bowel disease: is there a risk for the (unborn) child?All-trans retinoic acid down-regulates inflammatory responses by shifting the Treg/Th17 profile in human ulcerative and murine colitis.Modulation of inflammatory response via alpha2-adrenoceptor blockade in acute murine colitis.Analytical Pitfalls of Therapeutic Drug Monitoring of Thiopurines in Patients With Inflammatory Bowel Disease.

P2860

Q24616161-2E4A7EF4-D1CC-455A-B998-95B0C786CA0C Q26824662-3DDDCD34-D3BE-4644-B32D-D4D71D13DF55 Q26859122-37605EBF-3118-4F23-8434-6D62396E6A3F Q28076561-925884BF-782A-4EF8-8C6A-B8F13112544A Q28082687-C552FE0A-8F78-4EB4-B232-B91BD1F83030 Q28115755-F748D992-55D4-4599-B0CA-C8A4635D1A3B Q30492009-E551016E-B28F-48B0-BE45-D11D4FCACFF0 Q33391514-3C4EB2A1-FFC0-4296-8035-C2BF140C68BA Q33410771-E694C6B2-EB81-4A6F-94D4-7E5023AA7304 Q33420121-B0B7E087-690B-4345-8BB1-1D590D78B23D Q33436894-6CD9428C-1005-430E-98F4-61C743CA9FD5 Q33696379-14FCA091-D33D-4749-8289-7C7807740F96 Q33890504-12C7D42C-D2F8-40DF-9A46-5905F3E66982 Q34112953-E34E9963-754A-43E8-BDAF-F75B5A964A7F Q35036160-BAB0C2D8-27C8-4EA7-AB03-4181477CB9AF Q35187475-4F40C506-BB46-4D5F-AD2A-780DB73C1A59 Q36715034-DFC368D5-3698-4831-A415-6AD7AA741A70 Q37034422-D9597AE4-9A2F-4EB4-9555-974A4FCA4885 Q37100757-B13D3CE2-F3F2-46A8-B12D-7BB446F7EE9F Q37318035-4AAFB385-239D-4BCD-A6BA-238EEC934B2B Q37373306-3EF1C6DD-79A5-4B74-A854-79BC20EF598A Q37629675-318153A5-185E-483F-B221-4376AA56BA7F Q37636108-71A9E31B-4711-4E02-8D73-5809D58E1F60 Q37817487-6BD542EA-2F65-439D-ACA9-37E18CAC5804 Q38081399-B4F9771F-A94D-420F-BD51-F1AB64F5FDB7 Q38237701-6ECF70B7-1B07-4655-9E4A-5349F7020149 Q38269017-D5D0497C-68BD-40DA-B480-672FC9461B5D Q38295916-DA25374A-8FC5-4C95-8F23-A854047D400D Q38443981-1BBA1C4B-FFE7-4FBF-9EAF-DD7A6913CE95 Q38618602-6D8937B8-29DE-44BD-97F4-7C7DE607D182 Q38701511-399126E3-0677-4E57-9079-A9463F34D929 Q38833865-9EA7323E-FE70-47B5-AA58-6AC7BF624A89 Q41198135-F8FB9F19-5632-409D-B383-938B78E22388 Q41302949-820D66A7-8E8F-4C40-8B05-6137DA137335 Q43162040-1FD0DC39-6261-4959-8668-2E817954E519 Q43758596-22F74416-2019-4792-B831-67D8D5F4AF10 Q44433747-B91710AA-4CD6-4337-8069-1F630ECF828B Q45991876-9E51ACB0-98D5-4D5A-AF42-08933240E1F9 Q46105481-BAD7F7A6-E077-4F99-9E72-E367A7B50B92 Q47426181-2FC2FEBF-359A-4C71-9ECC-D527B6CAAE54

P2860

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

http://www.wikidata.org/entity/Q28258977

description

2007 nî lūn-bûn

@nan

2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@ast

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@en

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@nl

type

label

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@ast

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@en

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@nl

prefLabel

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@ast

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@en

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@nl

P1433

Q28258977-B9C15FE4-565B-47AD-9AA3-D61D66B1F4C4

P1476

Q28258977-B63ECA3D-E803-4A73-AAD2-388F3BB02121

P2093

Q28258977-12C1609F-D00D-4A5E-9DD6-9C53D4F4DC83

Q28258977-346E6B88-25EB-4AD2-AFCC-71C6AE3FA637

Q28258977-AC379C11-C54E-488F-8D56-F0A10FEDA66C

Q28258977-DA68AAE6-E2E8-4667-899C-7F9157362E6E

Q28258977-F0DCB6D5-1988-400F-B397-FB8228C22907

P2860

Q28258977-5520DFA2-58F0-4F9D-9721-21B1B4A74DDD

Q28258977-61E8A78C-D7E0-428D-8662-307482B83291

Q28258977-675306FB-588F-4641-BADE-2227D4171EDD

Q28258977-DF713EE6-52C8-44F1-B81E-8DE830EC27B4

P2888

Q28258977-61251EB1-FBC2-47DA-B9E9-E442E38B0B5B

P304

Q28258977-9E0C97DF-ACC0-4C1C-88BC-C69AF8E4613A

P31

Q28258977-53A1E353-A8D9-475A-B7E1-2C8FBEAAB282

P3181

Q28258977-E8ECFFE8-DCCE-49DB-B777-8C90A52AF80A

P356

Q28258977-28CD872D-CC6F-4BDB-885A-A4DBE099AB40

P407

Q28258977-1511D63C-9219-4305-95EA-4B02FB9DA532

P433

Q28258977-55E1992E-820C-44AB-913A-76345527EC46

P478

Q28258977-69AEE7B0-5966-4B49-A90A-3192B7C2557A

P577

Q28258977-22EDB113-833C-4C91-B22E-AC4BB348D5E0

P5875

Q28258977-7FCFFBEA-FD8D-489B-836A-17562D5D7A46

P698

Q28258977-F9AFC68D-826E-4EA0-BD70-4DF36FB10355

P921

Q28258977-03A7C3DA-2E36-4511-8879-DACEED5F0FA8

Q28258977-7714EA30-B20B-40B2-83B4-BD05A23DADE4

P3181

P356

P1433

Nature Reviews Gastroenterology & Hepatology

P1476

Drug Insight: pharmacology and toxicity of thiopurine therapy in patients with IBD

@en

P2093

Adriaan A van Bodegraven

http://www.w3.org/2001/XMLSchema#string

Bindia Jharap

http://www.w3.org/2001/XMLSchema#string

Chris J J Mulder

http://www.w3.org/2001/XMLSchema#string

Nanne K H de Boer

http://www.w3.org/2001/XMLSchema#string

Peer de Graaf

http://www.w3.org/2001/XMLSchema#string

P2860

Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia?

On tolerability and safety of a maintenance treatment with 6-thioguanine in azathioprine or 6-mercaptopurine intolerant IBD patients

Azathioprine suppresses ezrin-radixin-moesin-dependent T cell-APC conjugation through inhibition of Vav guanosine exchange activity on Rac proteins.

Differential control of cell cycle, proliferation, and survival of primary T lymphocytes by purine and pyrimidine nucleotides.

P2888

P304

686-94

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2709206

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NCPGASTHEP1000

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5803570

http://www.w3.org/2001/XMLSchema#string

P698

18043678

http://www.w3.org/2001/XMLSchema#string

P921